First-in-human trial results of RET targeted BLU-667
First-in-human trial results of RET targeted BLU-667
Treating RET alterations with novel therapy BLU-667
The importance of online patient groups and 'The ROS1ders'
Results from GOBACK: Non-chromosomal birth defects linked with cancer
A link between non-chromosomal birth defects and cancer
Novel gene biomarkers in multiple cancers derived from non-malignant breast phenotypes
Clinical development and economic prospects of CAR T cell immunotherapies
Theranostic imaging of lymphoma using radiolabelled αCD19-antibodies
Response and safety profile of neoadjuvant nivolumab for resectable lung cancer
Doubled survival in metastatic lung cancer with combination therapy
Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer
Results from CheckMate-227 : Immune combination reaches PFS endpoint